• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种中药复方的保肝作用:实验证据及基于网络药理学的作用机制和潜在生物活性成分鉴定。

Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components.

机构信息

School of Chinese Medicine, The University of Hong Kong, Hong Kong, China.

Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518057, China.

出版信息

Molecules. 2018 Feb 7;23(2):352. doi: 10.3390/molecules23020352.

DOI:10.3390/molecules23020352
PMID:29414910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6017312/
Abstract

Various Chinese herbal medicines (CHMs) have shown beneficial liver protection effects. Jian-Gan-Bao (JGB), a functional herbal formula, consists of three famous CHMs, including , and , which has been used as a folk medicine for several chronic liver diseases. In the present study, we aim systemically to evaluate the effects of JGB on acute and chronic alcoholic liver diseases (ALD) as well as non-alcoholic fatty liver disease (NAFLD) in mouse models, and identify its potential bioactive components and mechanism of action. JGB showed preventive effects for acute and chronic ALD as well as NAFLD, while post-treatment of JGB showed no significant effect, suggesting the nature of JGB as a health supplement rather than a drug. Furthermore, a compound-target network was constructed to identify the potential bioactive compounds and pathways that regulate its hepatoprotective effects. There are 40 bioactive compounds and 15 related targets that have been identified via this network pharmacology study. Among them are miltirone, neocryptotanshinone II and deoxyshikonin, with desirable pharmaceutical properties. Pathways relating to inflammation, fatty acid oxidation, tumor necrosis factor (TNF) production and cell proliferation were predicted as bioactive compounds and potential underlying mechanisms, which should be the focus of study in this field in the future.

摘要

各种中草药(CHM)已显示出对肝脏有益的保护作用。健肝宝(JGB)是一种功能性中草药配方,由三种著名的中草药组成,包括 、 和 ,它已被用作几种慢性肝病的民间药物。在本研究中,我们旨在系统地评估 JGB 对急性和慢性酒精性肝病(ALD)以及非酒精性脂肪性肝病(NAFLD)的作用,鉴定其潜在的生物活性成分和作用机制。JGB 对急性和慢性 ALD 以及 NAFLD 具有预防作用,而 JGB 的后期治疗则没有明显效果,这表明 JGB 性质上是一种保健品,而不是药物。此外,还构建了一个化合物-靶标网络,以鉴定调节其肝保护作用的潜在生物活性化合物和途径。通过这项网络药理学研究,共鉴定出 40 种生物活性化合物和 15 个相关靶点。其中包括 miltirone、neocryptotanshinone II 和 deoxyshikonin,它们具有良好的药物特性。预测与炎症、脂肪酸氧化、肿瘤坏死因子(TNF)产生和细胞增殖相关的途径为生物活性化合物和潜在的潜在机制,这应该是该领域未来研究的重点。

相似文献

1
Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components.三种中药复方的保肝作用:实验证据及基于网络药理学的作用机制和潜在生物活性成分鉴定。
Molecules. 2018 Feb 7;23(2):352. doi: 10.3390/molecules23020352.
2
A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.丹参保肝作用的生物医学研究及基于网络药理学的活性成分与分子靶点预测
Int J Mol Sci. 2017 Mar 13;18(3):620. doi: 10.3390/ijms18030620.
3
Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology.基于网络药理学的五味子活性成分对小鼠肝损伤的作用及其机制研究。
Eur J Pharmacol. 2021 Nov 5;910:174442. doi: 10.1016/j.ejphar.2021.174442. Epub 2021 Sep 4.
4
A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.基于网络药理学的五味子护肝作用研究。
Molecules. 2017 Sep 28;22(10):1617. doi: 10.3390/molecules22101617.
5
Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.基于网络药理学和 KKAy 小鼠模型探讨生脉饮合甘麦大枣汤防治 2 型糖尿病合并非酒精性脂肪肝病的作用机制。
J Ethnopharmacol. 2019 Oct 5;242:112029. doi: 10.1016/j.jep.2019.112029. Epub 2019 Jun 16.
6
CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model.CGplus,一种标准化草药配方,可改善他莫昔芬诱导的小鼠非酒精性脂肪性肝炎。
Phytomedicine. 2018 Mar 1;41:24-32. doi: 10.1016/j.phymed.2018.01.020. Epub 2018 Jan 31.
7
Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.基于脂质组学分析的参苓白术散防治非酒精性脂肪肝大鼠的作用机制研究
Molecules. 2019 Oct 31;24(21):3943. doi: 10.3390/molecules24213943.
8
[Advance in studies on hepatoprotective effect of Salvia miltiorrhiza and its main components].[丹参及其主要成分肝脏保护作用的研究进展]
Zhongguo Zhong Yao Za Zhi. 2015 Feb;40(4):588-93.
9
Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.五味子多糖通过下调非酒精性脂肪性肝病(NAFLD)小鼠中固醇调节元件结合蛋白(SREBPs)的表达来抑制肝脏脂质积累。
Lipids Health Dis. 2016 Nov 16;15(1):195. doi: 10.1186/s12944-016-0358-5.
10
Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.毛蕊异黄酮通过激活法尼醇 X 受体减轻非酒精性脂肪性肝炎小鼠模型的甘油三酯积累和肝纤维化。
Phytomedicine. 2017 Feb 15;25:83-92. doi: 10.1016/j.phymed.2016.12.006. Epub 2016 Dec 13.

引用本文的文献

1
Fufang Muji Granules Ameliorate Liver Fibrosis by Reducing Oxidative Stress and Inflammation, Inhibiting Apoptosis, and Modulating Overall Metabolism.复方木鸡颗粒通过减轻氧化应激和炎症、抑制细胞凋亡以及调节整体代谢来改善肝纤维化。
Metabolites. 2024 Aug 11;14(8):446. doi: 10.3390/metabo14080446.
2
Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review.基于网络药理学的中医治疗非酒精性脂肪性肝病研究进展
Front Pharmacol. 2024 Apr 17;15:1381712. doi: 10.3389/fphar.2024.1381712. eCollection 2024.
3
Therapeutic efficacy and pharmacological mechanism of Yindan Xinnaotong soft capsule on acute ischemic stroke: a meta-analysis and network pharmacology analysis.

本文引用的文献

1
A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines.基于网络药理学的传统保肝中草药致肝损伤潜力研究
Molecules. 2017 Apr 14;22(4):632. doi: 10.3390/molecules22040632.
2
A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.丹参保肝作用的生物医学研究及基于网络药理学的活性成分与分子靶点预测
Int J Mol Sci. 2017 Mar 13;18(3):620. doi: 10.3390/ijms18030620.
3
Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review.
银丹心脑通软胶囊治疗急性缺血性脑卒中的疗效及作用机制的Meta 分析和网络药理学研究。
Metab Brain Dis. 2024 Apr;39(4):523-543. doi: 10.1007/s11011-023-01337-w. Epub 2023 Dec 29.
4
lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines.木脂素通过调节磷脂酰乙醇胺的异常代谢来改善非酒精性脂肪性肝炎。
Acta Pharm Sin B. 2023 Aug;13(8):3545-3560. doi: 10.1016/j.apsb.2023.04.009. Epub 2023 Apr 23.
5
COVID-19 and Cancer Diseases-The Potential of Mushroom to Combat Global Health Challenges.新型冠状病毒肺炎与癌症——蘑菇应对全球健康挑战的潜力。
Int J Mol Sci. 2023 Mar 2;24(5):4864. doi: 10.3390/ijms24054864.
6
A Critical Appraisal of the Most Recent Investigations on the Hepatoprotective Action of Brazilian Plants.对巴西植物保肝作用最新研究的批判性评价
Plants (Basel). 2022 Dec 12;11(24):3481. doi: 10.3390/plants11243481.
7
Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and validation.运用网络药理学分析与验证,解读基于香料的配方三卡图对酒精性肝病的影响及作用机制。
Front Nutr. 2022 Nov 16;9:1063118. doi: 10.3389/fnut.2022.1063118. eCollection 2022.
8
Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.基于网络药理学和实验验证探究化积健脾汤对非酒精性脂肪性肝病的保护作用及机制
Evid Based Complement Alternat Med. 2022 Sep 26;2022:5440347. doi: 10.1155/2022/5440347. eCollection 2022.
9
Study on the Action Mechanism of the Yifei Jianpi Tongfu Formula in Treatment of Colorectal Cancer Lung Metastasis Based on Network Analysis, Molecular Docking, and Experimental Validation.基于网络分析、分子对接和实验验证的益肺健脾通腑方治疗结直肠癌肺转移作用机制研究
Evid Based Complement Alternat Med. 2022 Jul 30;2022:6229444. doi: 10.1155/2022/6229444. eCollection 2022.
10
Network Pharmacology Approach for Medicinal Plants: Review and Assessment.药用植物的网络药理学方法:综述与评估
Pharmaceuticals (Basel). 2022 May 4;15(5):572. doi: 10.3390/ph15050572.
天然产物治疗糖尿病的生物活性成分及作用机制的网络药理学研究综述
Front Pharmacol. 2017 Feb 23;8:74. doi: 10.3389/fphar.2017.00074. eCollection 2017.
4
Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.基于网络药理学及临床相关性的转移性乳腺癌患者中中药活性成分及潜在靶点预测
Oncotarget. 2017 Apr 18;8(16):27007-27021. doi: 10.18632/oncotarget.15351.
5
Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.洞悉氧化应激与炎症在肝脏疾病中的作用及相互依存关系
Oxid Med Cell Longev. 2016;2016:4234061. doi: 10.1155/2016/4234061. Epub 2016 Dec 14.
6
Diphenyl Dimethyl Bicarboxylate in the Treatment of Viral Hepatitis, Adjuvant or Curative?联苯双酯治疗病毒性肝炎,是辅助治疗还是有治愈作用?
Gastroenterology Res. 2008 Dec;1(1):2-7. doi: 10.4021/gr2008.10.1231. Epub 2008 Nov 20.
7
Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment.基于网络药理学的治疗阿尔茨海默病中草药作用机制研究。
J Ethnopharmacol. 2017 Jan 20;196:281-292. doi: 10.1016/j.jep.2016.11.034. Epub 2016 Nov 23.
8
Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.非酒精性脂肪性肝病的动物模型:当前观点与最新进展
J Pathol. 2017 Jan;241(1):36-44. doi: 10.1002/path.4829. Epub 2016 Nov 22.
9
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.患者特异性因素对肝脏药物反应和毒性的重要性。
Int J Mol Sci. 2016 Oct 12;17(10):1714. doi: 10.3390/ijms17101714.
10
Meta-analysis of traditional herbal medicine in the treatment of nonalcoholic fatty liver disease.传统草药治疗非酒精性脂肪性肝病的荟萃分析。
Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(4):88-95.